Clinical Trial Update: Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients [Phase 2]

View source ↗

Summary

Phase II clinical trial of AS1501 for acute-on-chronic liver failure in China is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• AS1501

Snippet

Sponsor: Shenzhen Third People's Hospital | Conditions: Acute-On-Chronic Liver Failure | Phase 2 | Status: NOT_YET_RECRUITING